158 related articles for article (PubMed ID: 38150061)
41. Impact of Bevacizumab on Visual Function, Tumor Size, and Toxicity in Pediatric Progressive Optic Pathway Glioma: A Retrospective Nationwide Multicentre Study.
Bennebroek CAM; van Zwol J; Porro GL; Oostenbrink R; Dittrich ATM; Groot ALW; Pott JW; Janssen EJM; Bauer NJ; van Genderen MM; Saeed P; Lequin MH; de Graaf P; Schouten-van Meeteren AYN
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551572
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in children.
Marsault P; Ducassou S; Menut F; Bessou P; Havez-Enjolras M; Chateil JF
Neuroradiology; 2019 Jun; 61(6):711-720. PubMed ID: 30904949
[TBL] [Abstract][Full Text] [Related]
43. The impact of coexisting genetic mutations on murine optic glioma biology.
Kaul A; Toonen JA; Gianino SM; Gutmann DH
Neuro Oncol; 2015 May; 17(5):670-7. PubMed ID: 25246427
[TBL] [Abstract][Full Text] [Related]
44. Investigation of retinal nerve fiber layer thickness and ganglion cell layer-inner plexiform layer thickness in patients with optic pathway gliomas.
Hepokur M; Sarici AM
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1757-1765. PubMed ID: 29754292
[TBL] [Abstract][Full Text] [Related]
45. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.
Fisher MJ; Loguidice M; Gutmann DH; Listernick R; Ferner RE; Ullrich NJ; Packer RJ; Tabori U; Hoffman RO; Ardern-Holmes SL; Hummel TR; Hargrave DR; Bouffet E; Charrow J; Bilaniuk LT; Balcer LJ; Liu GT
Neuro Oncol; 2012 Jun; 14(6):790-7. PubMed ID: 22474213
[TBL] [Abstract][Full Text] [Related]
46. Non-inferiority of a non-gadolinium-enhanced magnetic resonance imaging follow-up protocol for isolated optic pathway gliomas.
Maloney E; Perez FA; Iyer RS; Otto RK; Wright JN; Menashe SJ; Hippe DS; Shaw DWW; Stanescu AL
Pediatr Radiol; 2022 Mar; 52(3):539-548. PubMed ID: 34751813
[TBL] [Abstract][Full Text] [Related]
47. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.
Sharif S; Ferner R; Birch JM; Gillespie JE; Gattamaneni HR; Baser ME; Evans DG
J Clin Oncol; 2006 Jun; 24(16):2570-5. PubMed ID: 16735710
[TBL] [Abstract][Full Text] [Related]
48. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL
Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
[TBL] [Abstract][Full Text] [Related]
49. BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper.
Rodriguez FJ; Ligon AH; Horkayne-Szakaly I; Rushing EJ; Ligon KL; Vena N; Garcia DI; Cameron JD; Eberhart CG
J Neuropathol Exp Neurol; 2012 Sep; 71(9):789-94. PubMed ID: 22892521
[TBL] [Abstract][Full Text] [Related]
50. Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
Ullrich NJ; Prabhu SP; Packer RJ; Goldman S; Robison NJ; Allen JC; Viskochil DH; Gutmann DH; Perentesis JP; Korf BR; Fisher MJ; Kieran MW;
Pediatr Blood Cancer; 2021 Apr; 68(4):e28833. PubMed ID: 33336845
[TBL] [Abstract][Full Text] [Related]
51. Natural history and outcome of optic pathway gliomas in children.
Nicolin G; Parkin P; Mabbott D; Hargrave D; Bartels U; Tabori U; Rutka J; Buncic JR; Bouffet E
Pediatr Blood Cancer; 2009 Dec; 53(7):1231-7. PubMed ID: 19621457
[TBL] [Abstract][Full Text] [Related]
52. Optic pathway glioma in children: 10 years of experience in a single institution.
Doganis D; Pourtsidis A; Tsakiris K; Baka M; Kouri A; Bouhoutsou D; Varvoutsi M; Servitzoglou M; Dana H; Kosmidis H
Pediatr Hematol Oncol; 2016 Mar; 33(2):102-8. PubMed ID: 27007263
[TBL] [Abstract][Full Text] [Related]
53. Automatic segmentation, classification, and follow-up of optic pathway gliomas using deep learning and fuzzy c-means clustering based on MRI.
Artzi M; Gershov S; Ben-Sira L; Roth J; Kozyrev D; Shofty B; Gazit T; Halag-Milo T; Constantini S; Ben Bashat D
Med Phys; 2020 Nov; 47(11):5693-5701. PubMed ID: 32969025
[TBL] [Abstract][Full Text] [Related]
54. Diencephalic syndrome as sign of tumor progression in a child with neurofibromatosis type 1 and optic pathway glioma: a case report.
Cavicchiolo ME; Opocher E; Daverio M; Bendini M; Viscardi E; Bisogno G; Perilongo G; Da Dalt L
Childs Nerv Syst; 2013 Oct; 29(10):1941-5. PubMed ID: 23615855
[TBL] [Abstract][Full Text] [Related]
55. NF1 mutation drives neuronal activity-dependent initiation of optic glioma.
Pan Y; Hysinger JD; Barron T; Schindler NF; Cobb O; Guo X; Yalçın B; Anastasaki C; Mulinyawe SB; Ponnuswami A; Scheaffer S; Ma Y; Chang KC; Xia X; Toonen JA; Lennon JJ; Gibson EM; Huguenard JR; Liau LM; Goldberg JL; Monje M; Gutmann DH
Nature; 2021 Jun; 594(7862):277-282. PubMed ID: 34040258
[TBL] [Abstract][Full Text] [Related]
56. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226
[TBL] [Abstract][Full Text] [Related]
57. Neurofibromatosis Type 1: Description of a Novel Diagnostic Scoring System in Pediatric Optic Nerve Glioma.
Eid H; Crevier-Sorbo G; Aldraihem A; Menegotto F; Wilson N
AJR Am J Roentgenol; 2019 Apr; 212(4):892-898. PubMed ID: 30741560
[TBL] [Abstract][Full Text] [Related]
58. Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology.
Toonen JA; Solga AC; Ma Y; Gutmann DH
J Exp Med; 2017 Jan; 214(1):17-25. PubMed ID: 27923908
[TBL] [Abstract][Full Text] [Related]
59. MR Imaging Characteristics and ADC Histogram Metrics for Differentiating Molecular Subgroups of Pediatric Low-Grade Gliomas.
Shrot S; Kerpel A; Belenky J; Lurye M; Hoffmann C; Yalon M
AJNR Am J Neuroradiol; 2022 Sep; 43(9):1356-1362. PubMed ID: 36007944
[TBL] [Abstract][Full Text] [Related]
60. Optic Pathway Gliomas in Neurofibromatosis Type 1.
Campen CJ; Gutmann DH
J Child Neurol; 2018 Jan; 33(1):73-81. PubMed ID: 29246098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
